Cargando…

Stem-Like Signature Predicting Disease Progression in Early Stage Bladder Cancer. The Role of E2F3 and SOX4

The rapid development of the cancer stem cells (CSC) field, together with powerful genome-wide screening techniques, have provided the basis for the development of future alternative and reliable therapies aimed at targeting tumor-initiating cell populations. Urothelial bladder cancer stem cells (BC...

Descripción completa

Detalles Bibliográficos
Autor principal:	Bellmunt, Joaquim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164884/ https://www.ncbi.nlm.nih.gov/pubmed/30072631 http://dx.doi.org/10.3390/biomedicines6030085

Ejemplares similares

SOX2 Is a Marker for Stem-like Tumor Cells in Bladder Cancer
por: Zhu, Fengyu, et al.
Publicado: (2017)

Sox4 Expression Confers Bladder Cancer Stem Cell Properties and Predicts for Poor Patient Outcome
por: Shen, He, et al.
Publicado: (2015)

Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma
por: Lengerke, Claudia, et al.
Publicado: (2011)

Stem signatures associating SOX2 antibody helps to define diagnosis and prognosis prediction with esophageal cancer
por: Peng, Zi-Yang, et al.
Publicado: (2022)

Prognostic and predictive value of ALDH1, SOX2 and SSEA-4 in bladder cancer
por: Blomqvist, Matias, et al.
Publicado: (2021)

Role of SOX Protein Groups F and H in Lung Cancer Progression
por: Olbromski, Mateusz, et al.
Publicado: (2020)

Stem Cell Determinant SOX9 Promotes Lineage Plasticity and Progression in Basal-like Breast Cancer
por: Christin, John R., et al.
Publicado: (2020)

Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2
por: Zhan, Yonghao, et al.
Publicado: (2020)

Predictive Value of Stemness Factor Sox2 in Gastric Cancer Is Associated with Tumor Location and Stage
por: Yang, Lang, et al.
Publicado: (2017)

Correction: Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2
por: Zhan, Yonghao, et al.
Publicado: (2023)

Identification of an Individualized Prognostic Signature Based on the RWSR Model in Early-Stage Bladder Carcinoma
por: Liu, Liyang, et al.
Publicado: (2020)

Sox2 is associated with cancer stem-like properties in colorectal cancer
por: Takeda, Koki, et al.
Publicado: (2018)

Diagnostic SOX10 gene signatures in salivary adenoid cystic and breast basal-like carcinomas
por: Ivanov, S V, et al.
Publicado: (2013)

E2F1 Mediates SOX17 Deficiency-Induced Pulmonary Hypertension
por: Yi, Dan, et al.
Publicado: (2023)

Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays
por: Aleman, A, et al.
Publicado: (2008)

SoxE group transcription factor Sox8 promotes astrocytic differentiation of neural stem/precursor cells downstream of Nfia
por: Takouda, Jun, et al.
Publicado: (2021)

Sox12 Is a Cancer Stem-Like Cell Marker in Hepatocellular Carcinoma
por: Zou, Song, et al.
Publicado: (2017)

The Expression of Connexins and SOX2 Reflects the Plasticity of Glioma Stem-Like Cells
por: Balça-Silva, Joana, et al.
Publicado: (2017)

Gene Expression Signature Differentiates Histology But Not Progression Status of Early-Stage NSCLC()
por: Charkiewicz, Radoslaw, et al.
Publicado: (2017)

The interactomes of POU5F1 and SOX2 enhancers in human embryonic stem cells
por: Gao, Fan, et al.
Publicado: (2013)

Identification of a gene signature for the prediction of recurrence and progression in non-muscle-invasive bladder cancer
por: Dalla, Emiliano, et al.
Publicado: (2022)

DDX53 Regulates Cancer Stem Cell-Like Properties by Binding to SOX-2
por: Kim, Youngmi, et al.
Publicado: (2017)

Sox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage
por: Finzsch, Markus, et al.
Publicado: (2010)

Gene signature developed for predicting early relapse and survival in early-stage pancreatic cancer
por: Huang, Lei, et al.
Publicado: (2023)

The E2F4 prognostic signature is also predictive of the pathological response of breast cancer to chemotherapy
por: Bertucci, François, et al.
Publicado: (2015)

Putting SUMO and SoxE into context
por: Short, Ben
Publicado: (2012)

An integrated analysis of prognostic mRNA signature in early- and progressive-stage gastric adenocarcinoma
por: Hong, Xiaoling, et al.
Publicado: (2023)

Identification of a 13-mRNA signature for predicting disease progression and prognosis in patients with bladder cancer
por: Yin, Hubin, et al.
Publicado: (2020)

Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer
por: Wang, Ruiliang, et al.
Publicado: (2021)

SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells
por: Herreros-Villanueva, M, et al.
Publicado: (2013)

Impact of SOX2 function and regulation on therapy resistance in bladder cancer
por: Chen, Guodong, et al.
Publicado: (2022)

Cancer stem cells and early stage basal-like breast cancer
por: Lo, Pang-Kuo, et al.
Publicado: (2016)

Functional and molecular characterization of cancer stem-like cells in bladder cancer: a potential signature for muscle-invasive tumors
por: Ferreira-Teixeira, Margarida, et al.
Publicado: (2015)

Screening potential immune signatures for early-stage basal-like/triple-negative breast cancer
por: Wu, Min, et al.
Publicado: (2022)

The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients
por: Mark, Kenneth M. K., et al.
Publicado: (2017)

E2F signature is predictive for the pancreatic adenocarcinoma clinical outcome and sensitivity to E2F inhibitors, but not for the response to cytotoxic-based treatments
por: Lan, Wenjun, et al.
Publicado: (2018)

EGFR enhances the stemness and progression of oral cancer through inhibiting autophagic degradation of SOX2
por: Lv, Xiao‐Xi, et al.
Publicado: (2019)

Novel protein signatures suggest progression to muscular invasiveness in bladder cancer
por: Berle, Magnus, et al.
Publicado: (2018)

SOX4 regulates invasion of bladder cancer cells via repression of WNT5a
por: Moran, Josue D., et al.
Publicado: (2019)

MTA3 Represses Cancer Stemness by Targeting the SOX2OT/SOX2 Axis
por: Du, Liang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_57v41iot0o723lshaf90j1tiir